Calder Biosciences

Improving & Saving Lives with next-generation subunit vaccines

New York, United States · Founded 2018 · $6.9M raised

Headquarters
New York, New York
Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$6.9M
Last Round
$275K Venture RoundMay 2025
Rounds
5

About

Calder Biosciences, Inc. is a nano-scale molecular engineering company applying its 3D-Vaxlock™ platform technology to develop conformationally stabilized prefusion subunit vaccines against RSV, universal influenza, and other viral pathogens. The company engineers site-specific, covalent crosslinks into proteins to lock immunogens in their most potent 3D shape, eliciting highly protective immune responses.

Summary

Calder Biosciences is a Biotech company based in New York, United States, founded in 2018. It has raised $6.9M in total across 5 rounds, most recently a $275K Venture Round in May 2025. Investors include SOSV and IndieBio.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundMay 2025
$275K

Sign up to see all 5 events

Funding: Grant through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Calder Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/calder-biosciences"><img src="https://indexed.vc/api/badge/company/calder-biosciences" alt="Calder Biosciences on Indexed.vc" width="260" height="76" /></a>